A Drop of Blood That Could Save Millions: The Future of Preeclampsia Diagnosis

A Drop of Blood That Could Save Millions: The Future of Preeclampsia Diagnosis

Author: by FemmeHealth Alliance August 7, 2025 Duration: 26:06

In this episode, healthcare investor and strategist Maryann Umoren Selfe is joined by Matthias Wipf, CEO of Swiss medtech company MOMM Diagnostics, to examine the systemic gaps in how we identify and fund life-saving healthcare infrastructure for women.

🟣 Why preeclampsia remains one of the most dangerous, misunderstood pregnancy complications

🟣 What point-of-care diagnostics like Pre-Exclude are doing differently

🟣 Why diagnostics in women’s health are underfunded and what that reveals about investor psychology

🟣 How preeclampsia connects to long-term cardiovascular risk 🟣 What’s holding back innovation in maternal health and how to change it

🟣 Why investing in maternal health benefits not just women, but entire health systems

Join 10,000+ readers of the FemmeHealth newsletter on Substack.

------------------

About MOMM Diagnostics:Founded in 2018, MOMM Diagnostics is reimagining maternal care with préXclude, a breakthrough test for early detection of preeclampsia. With just a drop of blood and a few minutes, their technology gives clinicians the power to act before pregnancy complications become emergencies. Born out of research collaborations in Switzerland and California, MOMM is part of a new wave of founders who are turning overlooked health problems into high-impact innovation. Learn more here.



Get full access to The Billion Dollar Blindspot at blog.billiondollarblindspot.com/subscribe

There's a vast, often overlooked frontier in business and innovation, and Blindspot Capital is mapping its terrain. This podcast digs into the ideas, trends, and tangible investment potential shaping the future of women's health, a sector that has historically been underfunded and underserved. Each episode moves beyond surface-level discussions to examine the systemic gaps and the consequential opportunities they create. You'll hear from founders, investors, researchers, and thinkers who are actively building and funding solutions in this space, sharing their on-the-ground experiences and hard-won insights. The conversations are grounded in the reality of entrepreneurship and market dynamics, exploring not just the "why" but the "how"-how new technologies are being applied, how businesses are scaling, and how capital can be deployed to generate both impact and returns. Tune in for a clear-eyed look at an area ripe for transformation, where understanding the blind spot isn't just about awareness, but about seeing a path forward for savvy builders and backers alike. This isn't a niche side conversation; it's a central dialogue about the next wave of growth in healthcare and technology, delivered through a podcast dedicated to substantive, forward-thinking analysis.
Author: Language: English Episodes: 18

Blindspot Capital
Podcast Episodes
What Real Science in Women’s Health Looks Like [not-audio_url] [/not-audio_url]

Duration: 25:15
Half the population experiences these conditions. Many are universal, recurring, and clinically significant. Yet in the eyes of too many investors, women’s health therapeutics remain “optional.”In this episode of Blindsp…
Blind Spot Capital is Here! [not-audio_url] [/not-audio_url]

Duration: 1:14
Blind Spot Capital Podcast TrailerWelcome to Blind Spot Capital, the podcast where health innovation meets investment insight. Every year, investors bet billions on the future of health but most still miss one of the big…
Episode #6: This Startup Is Changing the Way We Detect Cervical Cancer [not-audio_url] [/not-audio_url]

Duration: 33:33
A few weeks ago, Ronald Vos and Nutte van Belzen, the founders of CC Diagnostics were at a major European medical congress when they were approached by a woman who didn’t work in science or medicine. She had bought an ex…
Episode #5: Transforming PostPartum Care with AI [not-audio_url] [/not-audio_url]

Duration: 52:08
In this conversation, Maryann and Astrid Gyllenkrok, CEO and Co-Founder of LEIA Health discuss the challenges of parenthood, particularly focusing on the postpartum experience and the need for better support systems for…
Episode #4: Breaking Barriers in Drug Delivery for Women [not-audio_url] [/not-audio_url]

Duration: 31:14
In this episode of FemmeHealth Founders, Maryann speaks with Dr. Lara Zibners, co-founder of Calla Lily Clinical Care, about the inadequacies in current drug delivery methods for women's health. Lara shares her personal…
Episode #3 - The Story Behind OvulaRing [not-audio_url] [/not-audio_url]

Duration: 40:25
In this episode of Notes to Selfe, we dive into the fascinating world of women's health innovation with Sebastian Alexander, founder and CEO of VivoSensMedical. We explore the journey of OvulaRing, a groundbreaking techn…
Femme Health Founders Episode #1 [not-audio_url] [/not-audio_url]

Duration: 29:43
Hormones rule our lives—from puberty to menopause, they influence everything from our mood to our health. But why do some women experience severe side effects while others don’t?In this episode of the FemmeHealth Founder…